Efficacy and predictors of virological non-suppression in Thailand's rollout of dolutegravir-based first-line antiretroviral therapy: A nationwide cohort analysis.
Saved in:
| Title: | Efficacy and predictors of virological non-suppression in Thailand's rollout of dolutegravir-based first-line antiretroviral therapy: A nationwide cohort analysis. |
|---|---|
| Authors: | Hiranburana N; HIVNAT, Thai Red Cross AIDS and Infectious Diseases Research Centre, Bangkok, Thailand.; Center of Excellence in Tuberculosis, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand., Sophonphan J; HIVNAT, Thai Red Cross AIDS and Infectious Diseases Research Centre, Bangkok, Thailand.; Research Affairs, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand., Kerr SJ; HIVNAT, Thai Red Cross AIDS and Infectious Diseases Research Centre, Bangkok, Thailand.; Research Affairs, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.; The Kirby Institute, University of New South Wales, Sydney, New South Wales, Australia., Lertpiriyasuwat C; Division of AIDS and STI, Department of Disease Control, Ministry of Public Health, Nonthaburi, Thailand., Noknoy S; Division of AIDS and STI, Department of Disease Control, Ministry of Public Health, Nonthaburi, Thailand., Jirajariyavej S; Taksin Hospital, Bangkok, Thailand., Fujitnirun C; Bhumibol Adulyadej Hospital, Bangkok, Thailand., Chetchotisakd P; Faculty of Medicine, Srinagarind Hospital, Khon Kaen University, Khon Kaen, Thailand., Lolekha R; Thai AIDS Society, Bangkok, Thailand., Bowonwatanuwong C; Thai AIDS Society, Bangkok, Thailand., Ruxrungtham K; HIVNAT, Thai Red Cross AIDS and Infectious Diseases Research Centre, Bangkok, Thailand.; Center of Excellence in Vaccine Research and Development, Chula Vaccine Research Center (Chula VRC), Bangkok, Thailand.; School of Global Health, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand., Putcharoen O; Division of Infectious Diseases, Department of Medicine, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand., Avihingsanon A; HIVNAT, Thai Red Cross AIDS and Infectious Diseases Research Centre, Bangkok, Thailand.; Center of Excellence in Tuberculosis, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand. |
| Source: | HIV medicine [HIV Med] 2026 Mar; Vol. 27 (3), pp. 459-470. Date of Electronic Publication: 2025 Dec 19. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Wiley Country of Publication: England NLM ID: 100897392 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1468-1293 (Electronic) Linking ISSN: 14642662 NLM ISO Abbreviation: HIV Med Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 41420262 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Efficacy and predictors of virological non-suppression in Thailand's rollout of dolutegravir-based first-line antiretroviral therapy: A nationwide cohort analysis. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Hiranburana+N%22">Hiranburana N</searchLink>; HIVNAT, Thai Red Cross AIDS and Infectious Diseases Research Centre, Bangkok, Thailand.; Center of Excellence in Tuberculosis, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.<br /><searchLink fieldCode="AU" term="%22Sophonphan+J%22">Sophonphan J</searchLink>; HIVNAT, Thai Red Cross AIDS and Infectious Diseases Research Centre, Bangkok, Thailand.; Research Affairs, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.<br /><searchLink fieldCode="AU" term="%22Kerr+SJ%22">Kerr SJ</searchLink>; HIVNAT, Thai Red Cross AIDS and Infectious Diseases Research Centre, Bangkok, Thailand.; Research Affairs, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.; The Kirby Institute, University of New South Wales, Sydney, New South Wales, Australia.<br /><searchLink fieldCode="AU" term="%22Lertpiriyasuwat+C%22">Lertpiriyasuwat C</searchLink>; Division of AIDS and STI, Department of Disease Control, Ministry of Public Health, Nonthaburi, Thailand.<br /><searchLink fieldCode="AU" term="%22Noknoy+S%22">Noknoy S</searchLink>; Division of AIDS and STI, Department of Disease Control, Ministry of Public Health, Nonthaburi, Thailand.<br /><searchLink fieldCode="AU" term="%22Jirajariyavej+S%22">Jirajariyavej S</searchLink>; Taksin Hospital, Bangkok, Thailand.<br /><searchLink fieldCode="AU" term="%22Fujitnirun+C%22">Fujitnirun C</searchLink>; Bhumibol Adulyadej Hospital, Bangkok, Thailand.<br /><searchLink fieldCode="AU" term="%22Chetchotisakd+P%22">Chetchotisakd P</searchLink>; Faculty of Medicine, Srinagarind Hospital, Khon Kaen University, Khon Kaen, Thailand.<br /><searchLink fieldCode="AU" term="%22Lolekha+R%22">Lolekha R</searchLink>; Thai AIDS Society, Bangkok, Thailand.<br /><searchLink fieldCode="AU" term="%22Bowonwatanuwong+C%22">Bowonwatanuwong C</searchLink>; Thai AIDS Society, Bangkok, Thailand.<br /><searchLink fieldCode="AU" term="%22Ruxrungtham+K%22">Ruxrungtham K</searchLink>; HIVNAT, Thai Red Cross AIDS and Infectious Diseases Research Centre, Bangkok, Thailand.; Center of Excellence in Vaccine Research and Development, Chula Vaccine Research Center (Chula VRC), Bangkok, Thailand.; School of Global Health, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.<br /><searchLink fieldCode="AU" term="%22Putcharoen+O%22">Putcharoen O</searchLink>; Division of Infectious Diseases, Department of Medicine, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.<br /><searchLink fieldCode="AU" term="%22Avihingsanon+A%22">Avihingsanon A</searchLink>; HIVNAT, Thai Red Cross AIDS and Infectious Diseases Research Centre, Bangkok, Thailand.; Center of Excellence in Tuberculosis, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22100897392%22">HIV medicine</searchLink> [HIV Med] 2026 Mar; Vol. 27 (3), pp. 459-470. <i>Date of Electronic Publication: </i>2025 Dec 19. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Wiley%22">Wiley </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>100897392 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1468-1293 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2214642662%22">14642662 </searchLink><i>NLM ISO Abbreviation: </i>HIV Med <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41420262 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1111/hiv.70178 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 459 Titles: – TitleFull: Efficacy and predictors of virological non-suppression in Thailand's rollout of dolutegravir-based first-line antiretroviral therapy: A nationwide cohort analysis. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Hiranburana N – PersonEntity: Name: NameFull: Sophonphan J – PersonEntity: Name: NameFull: Kerr SJ – PersonEntity: Name: NameFull: Lertpiriyasuwat C – PersonEntity: Name: NameFull: Noknoy S – PersonEntity: Name: NameFull: Jirajariyavej S – PersonEntity: Name: NameFull: Fujitnirun C – PersonEntity: Name: NameFull: Chetchotisakd P – PersonEntity: Name: NameFull: Lolekha R – PersonEntity: Name: NameFull: Bowonwatanuwong C – PersonEntity: Name: NameFull: Ruxrungtham K – PersonEntity: Name: NameFull: Putcharoen O – PersonEntity: Name: NameFull: Avihingsanon A IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 03 Text: 2026 Mar Type: published Y: 2026 Identifiers: – Type: issn-electronic Value: 1468-1293 Numbering: – Type: volume Value: 27 – Type: issue Value: 3 Titles: – TitleFull: HIV medicine Type: main |
| ResultId | 1 |
